Online citations, reference lists, and bibliographies.
← Back to Search

Gp60 Is An Albumin-binding Glycoprotein Expressed By Continuous Endothelium Involved In Albumin Transcytosis.

J. Schnitzer
Published 1992 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Albumin reduces capillary permeability and acts as a carrier for various small molecules. Recently, we identified a 60-kDa sialoglycoprotein (gp60) on the surface of cultured rat microvascular endothelial cells (MEC) that binds albumin and antiglycophorin serum (alpha-gp). We verified that alpha-gp recognizes the albumin-binding gp60 by affinity, purifying proteins from MEC extracts using immobilized albumin. gp60 was immunoblotted with alpha-gp only when the MEC extract was reacted with albumin and not in controls. We immunoprecipitated gp60 from biosynthetically radiolabeled MEC lysates and from extracts containing endothelial surface proteins of isolated rat hearts that were radioiodinated in situ. gp60 was immunoblotted selectively in rat tissue microvascular beds lined with continuous endothelium (heart, lung, diaphragm, fat, skeletal muscle, mesentery, and duodenal muscularis but not cortical brain) and not those exclusively lined with fenestrated or sinusoidal endothelium (adrenal, pancreas, liver, and small intestinal mucosa). MEC isolated from rat heart, lung, and epididymal fat pad expressed gp60 and bound albumin, whereas various nonendothelial cells and brain-derived MEC did not. gp60 is an albumin-binding glycoprotein expressed specifically on the surface of continuous endothelium that binds albumin apparently not only to initiate its transcytosis via plasmalemmal vesicles but also to increase capillary permselectivity.



This paper is referenced by
10.1038/nbt993
Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture
E. Durr (2004)
10.1016/0169-409X(95)00021-X
Modeling in vivo transfer of long-circulating polymers (two classes of long circulating polymers and factors affecting their transfer in vivo)
M. Papisov (1995)
10.7150/thno.38587
Transcytosis - An effective targeting strategy that is complementary to “EPR effect” for pancreatic cancer nano drug delivery
X. Liu (2019)
10.3389/fphys.2014.00299
Unraveling the mysteries of serum albumin—more than just a serum protein
A. Merlot (2014)
10.3109/10739689409148270
Cellular Aspects of Transvascular Exchange: A 40‐Year Perspective
E. M. Renkin (1994)
10.1038/nature02580
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy
P. Oh (2004)
Albumin in Acute Stroke (ALIAS) Trial-Part 2: A Phase III Randomized Multicenter Clinical Trial of High-Dose Human Albumin Therapy for Neuroprotection in Acute Ischemic Stroke
M. Ginsberg (2010)
10.1016/j.nut.2014.08.011
Nutritional factors in the prevention and management of coronary artery disease and heart failure.
U. Das (2015)
10.1007/978-3-319-16241-6_10
Nanoparticle Albumin-Bound Anticancer Agents
N. Desai (2015)
10.1152/PHYSREV.00001.2003
Transcytosis: crossing cellular barriers.
P. Tuma (2003)
10.1007/s004240050305
Characteristics of albumin binding to opossum kidney cells and identification of potential receptors
N. Brunskill (1997)
10.1007/s00418-001-0367-x
Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function
Richard D. Minshall (2001)
10.1016/j.exer.2019.02.018
Ultrastructural analysis of submacular choriocapillaris and its transport systems in AMD and aged control eyes
R. Grebe (2019)
10.1083/JCB.150.5.1057
Endothelial Cell-Surface Gp60 Activates Vesicle Formation and Trafficking via Gi-Coupled Src Kinase Signaling Pathway
R. Minshall (2000)
10.1038/SJ.KI.5000141
Renal albumin absorption in physiology and pathology.
H. Birn (2006)
10.1007/s13311-011-0040-6
Investigational Therapies for Ischemic Stroke: Neuroprotection and Neurorecovery
P. Sahota (2011)
CARRIER MEDIATED LIPID TRANSPORT
S. Covey (2003)
The protein corona of polymeric nanocarriers: characterization and impact on cellular uptake
S. Schöttler (2015)
10.1111/imr.12331
The multiple facets of FcRn in immunity
N. M. Stapleton (2015)
10.1152/AJPLUNG.00075.2004
Functional and morphological studies of protein transcytosis in continuous endothelia.
D. Predescu (2004)
10.1016/j.jconrel.2010.01.036
Endocytosis of nanomedicines.
G. Sahay (2010)
10.1007/978-981-10-2116-9_6
Nanoparticle Albumin-Bound Paclitaxel (Abraxane®)
N. Desai (2016)
10.1109/COMST.2017.2705740
Molecular Communication and Nanonetwork for Targeted Drug Delivery: A Survey
U. Chude-Okonkwo (2017)
10.1007/BF00711897
The blood-brain barrier: Cellular basis
R. Janzer (2004)
10.1016/S0006-2952(99)00224-5
Homing of negatively charged albumins to the lymphatic system: general implications for drug targeting to peripheral tissues and viral reservoirs.
P. J. Swart (1999)
10.1006/EXCR.1999.4652
Tyrosine phosphorylation of caveolin-1 in the endothelium.
T. Aoki (1999)
10.1152/JAPPL.2001.91.4.1487
Cytoskeletal regulation of pulmonary vascular permeability.
S. Dudek (2001)
Elektronenmikroskopische Analyse des Einflusses von Hydroxyethylstärke auf die endotheliale Permeabilität während des frühen akuten Lungenschadens in vivo
A. Basedow (2010)
10.1023/A:1020549311455
Giant membrane vesicles as a model to study cellular substrate uptake dissected from metabolism
D.P.Y. Koonen (2004)
Albumin: A Versatile Drug Carrier
(2016)
10.1016/0021-9150(94)90206-2
Effect of hyperlipidemic diets, proinflammatory agents and plasma expanders on leukocyte adhesion to the endothelium of aorta and carotid artery of rats.
M. Gabaldón (1994)
10.1016/1050-1738(93)90012-U
Update on the cellular and molecular basis of capillary permeability.
J. Schnitzer (1993)
See more
Semantic Scholar Logo Some data provided by SemanticScholar